◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Daiichi Sankyo Company, Limited (4568) Financial History

Name: Daiichi Sankyo Company, Limited (4568) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Daiichi Sankyo Company, Limited (4568) operates in the Drug Manufacturers - General industry and is headquartered in Chuo, Japan with about 20,171 employees. Its market capitalization is roughly JPY 5.10 trillion. In the fiscal year ended 2026-03-31, 4568 reported JPY 2.12T in revenue and JPY 259.9B in net income.

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally.

Interactive charts & full statements →

4568 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 2.12T	JPY 1.89T	JPY 1.60T	JPY 1.28T	—
Gross Profit	JPY 1.45T	JPY 1.47T	JPY 1.19T	JPY 915.0B	—
Operating Income (EBIT)	JPY 229.1B	JPY 331.9B	JPY 211.6B	JPY 120.6B	—
Net Income	JPY 259.9B	JPY 295.8B	JPY 200.7B	JPY 109.2B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4568 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 128.4B)	(JPY 114.3B)	(JPY 67.1B)	(JPY 54.6B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4568 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 4.01T	JPY 3.46T	JPY 3.46T	JPY 2.51T
Total Liabilities	JPY 2.34T	JPY 1.83T	JPY 1.77T	JPY 1.06T

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4568 viewer.

4568 Metric Deep Dives

Other Companies in Drug Manufacturers - General

4519 · Chugai Pharmaceutical Co., Ltd. — $11.70 trillion
4578 · Otsuka Holdings Co., Ltd. — $6.60 trillion
4503 · Astellas Pharma Inc. — $4.24 trillion
4528 · Ono Pharmaceutical Co., Ltd. — $1.14 trillion
4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4565 All “0-9” companies 4569 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.